🇺🇸 FDA
Patent

US 8535890

Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies

granted A61KA61K2039/505A61K51/1045

Quick answer

US patent 8535890 (Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies) held by The United of America as represented by the Secretary of the Department of Health and Human Services expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United of America as represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/505, A61K51/1045, A61P, A61P35/00